Feasibility of Cervical Cancer Screening Utilizing Self-sample Human Papillomavirus Testing Among Mexican Immigrant Women in Harris County, Texas: A Pilot Study

Journal of Immigrant and Minority Health

Volumn 17, Issue 3, 2015, Pages 704-712

  Montealegre, Jane R ^a   Mullen, Patricia D ^b   L Jibaja Weiss, Maria ^a   Vargas Mendez, Maria M ^b   Scheurer, Michael E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cervical cancer; Hispanics Latinos; Human papillomavirus; Immigrants; Screening; Self testing

Indexed keywords

ADULT; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; FEASIBILITY STUDY; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MEXICAN AMERICAN; MIGRANT; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT STUDY; SELF CARE; SPECIMEN HANDLING; TEXAS; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

ADULT; EARLY DETECTION OF CANCER; EMIGRANTS AND IMMIGRANTS; FEASIBILITY STUDIES; FEMALE; HUMANS; MEXICAN AMERICANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; SELF CARE; SPECIMEN HANDLING; TEXAS; UTERINE CERVICAL NEOPLASMS;

EID: 84930205213     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-014-0125-5     Document Type: Article

References (53)

1. Watson M, Saraiya M, Benard V, et al. Burden of cervical cancer in the United States, 1998–2003. Cancer. 2008;113(10 Suppl):2855–64.
2. Centers for Disease Control and Prevention (CDC). Invasive cervical cancer among Hispanic and non-Hispanic women–United States, 1992–1999. MMWR Morb Mortal Wkly Rep. 2002;51(47):1067–70.
3. Horner MJ, Altekruse SF, Zou Z, Wideroff L, Katki HA, Stinchcomb DG. U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev. 2011;20(4):591–9.
4. Texas Cancer Registry, Cancer Epidemiology and Surveillance Branch, Texas Department of State Health Services. Cancer statistics in Texas. 2014. https://www.dshs.state.tx.us/tcr/data.shtm. Accessed May 2 2014.
5. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2011. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
6. Montealegre JR, Zhou R, Amirian ES, Follen M, Scheurer ME. Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of surveillance, epidemiology, and end results data. Cancer Causes Control. 2013;24(11):1985–94.
7. Schur CL, Bernstein AB, Berk ML. The importance of distinguishing Hispanic subpopulations in the use of medical care. Med Care. 1987;25(7):627–41.
8. Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med. 2003;18(12):1028–35.
9. Singh GK, Hiatt RA. Trends and disparities in socioeconomic and behavioural characteristics, life expectancy, and cause-specific mortality of native-born and foreign-born populations in the United States, 1979–2003. Int J Epidemiol. 2006;35(4):903–19.
10. U.S. Preventive Services Task Force. Screening for cervical cancer: USA Preventive Services Task Force Recommendation Statement. 2012. http://www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm. Accessed 3 September 2014.
11. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.
12. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11(3):249–57.
13. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357(16):1579–88.
14. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385–94.
15. Anttila A, Kotaniemi-Talonen L, Leinonen M, et al. Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ. 2010;340:1804.
16. Leinonen M, Nieminen P, Kotaniemi-Talonen L, et al. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst. 2009;101(23):1612–23.
17. U.S. Food and Drug Administration (FDA). FDA News Release: FDA approves first human papillomavirus test for primary cervical cancer screening. 2014. http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm394773.htm. Accessed 5 June 2014.
18. Ogilvie GS, Patrick DM, Schulzer M, et al. Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis. Sex Transm Infect. 2005;81(3):207–12.
19. Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol. 2007;105(2):530–5.
20. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378(9806):1868–73.
21. Barbee L, Kobetz E, Menard J, et al. Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. Cancer Causes Control. 2010;21(3):421–31.
22. Petignat P, Vassilakos P. Is it time to introduce hpv self-sampling for primary cervical cancer screening? J Natl Cancer Inst. 2012;104(3):166–7.
23. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97(14):1072–9.
24. Dzuba IG, Diaz EY, Allen B, et al. The acceptability of self-collected samples for HPV testing versus the pap test as alternatives in cervical cancer screening. J Womens Health Gend Based Med. 2002;11(3):265–75.
25. De Alba I, Anton-Culver H, Hubbell FA, et al. Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2163–8.
26. Scarinci IC, Litton AG, Garces-Palacio IC, Partridege EE, Castle PE. Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta. Womens Health Issues. 2013;23(2):e123–30.
27. Castle PE, Rausa A, Walls T, et al. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med. 2011;52(6):452–5.
28. Léniz J, Barriga MI, Lagos M, Ibanez C, Pushchel K, Ferreccio C. HPV vaginal self-sampling among women non-adherent to Papanicolaou screening in Chile. Salud Publica Mex. 2013;55:162–9.
29. Trope LA, Chumworathayi B, Blumenthal PD. Feasibility of community-based careHPV for cervical cancer prevention in rural Thailand. J Low Genit Tract Dis. 2013;17(3):315–9.
30. Rosenbaum AJ, Gage JC, Alfaro KM, et al. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynecol Obst. 2014;126(2):156–60.
31. Bansil P, Wittet S, Lim JL, Winkler JL, Pail P, Jeronimo J. Acceptability of self-collection sampling for HPV-DNA testing in low-resource settings: a mixed methods approach. BMC Public Health. 2014;14(1):1–9.
32. Bais AG, van Kemenade FJ, Berkhof J, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer. 2007;120(7):1505–10.
33. Gok M, Heideman DA, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ. 2010;340:1040.
34. Gok M, vab Kemenade FJ, Heideman DA, et al. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program. Int J Cancer. 2012;130(5):1128–35.
35. Sanner K, Wikstrom I, Strand A, Lindell M, Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer. 2009;101(5):871–4.
36. Giorgi Rossi P, Marsili LM, Camilloni L, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer. 2011;104(2):248–54.
37. Virtanen A, Nieminen AP, Luostarinen T, Anttila A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1960–9.
38. Szarewski A, Cadman L, Mesher D, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening—a randomised controlled trial. Br J Cancer. 2011;104(6):915–20.
39. Piana L, Leanidri FX, Le Retraite L, Heid P, Tamalet C, Sancho-Garnier H. HPV–HR detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhone. Bull Cancer. 2011;98(7):723–31.
40. Wikstrom I, Lindell M, Sanner K, Wilander E. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study. Br J Cancer. 2011;105(3):337–9.
41. Migrant Clinicians Network. Ventanillas de Salud: Surge a traves de la necesidad. 2011. http://www.migrantclinician.org/services/ventanillas-de-salud.html. Accessed 19 Sept 2011.
42. Harris Health System. Patient financial assistance and eligibility. 2014. https://www.harrishealth.org/en/patients/access-care/eligibility-card/pages/default.aspx. Accessed 1 Sept 2014.
43. Selwyn BJ, Loe HD. The Valley Primary Health Review: a report of the Indigent Health Care Review Committee of the Health Planning Advisory Committee of the Lower Rio Grande Valley Development Council. 1989.
44. Montealegre JR, Selwyn BJ. Healthcare coverage and use among undocumented Central American immigrant women in Houston, Texas. J Immigr Minor Health. 2014;16(2):204–10.
45. Shi JF, Canfell K, Lew JB, et al. Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer. 2011;11:239.
46. Larkey L. Las mujeres saludables: reaching Latinas for breast, cervical and colorectal cancer prevention and screening. J Community Health. 2006;31(1):69–77.
47. Messias DK, Parra-Medina D, Sharpe PA, Trevino L, Koskan AM, Morales-Campos D. Promotoras de Salud: roles, responsibilities, and contributions in a multisite community-based randomized controlled trial. Hisp Health Care Int. 2013;11(2):62–71.
48. Saad-Harfouche FG, Jandor L, Gage E, Thelemaque LD, Colon J, Castillo AG, Erwin DO. Esperanza y Vida: training lay health advisors and cancer survivors to promote breast and cervical cancer screening in Latinas. J Community Health. 2011;36(2):219–27.
49. Fernandez M, Gonzales A, Tortolero-Luna G, Williams J, Saavedra-Embesi M, Chan W. Effectiveness of Cultivando la Salud: a bredast and cervical cancer screening promotion program for low-income Hispanic women. Am J Public Health. 2009;99(5):936–43.
50. Eperon I, Vassilakos P, Navarria I, et al. Randomized comparison of vaginal self-sampling by standard versus dry swabs for Human papillomavirus testing. BMC Cancer. 2013;13:353.
51. Haguenoer K, Giraudeau B, Gaudy-Graffin C, et al. Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: a cross-sectional study. Gynecol Oncol. 2014;134(2):302–8.
52. Wolfrum SG, Koutsky LA, Hughes JP, Feng Q, Xi LF, Shen Z, Winer RL. Evaluation of dry and wet transport of at-home self-collected vaginal swabs for human papillomavirus testing. J Med Microbiol. 2012;61(11):1538–45.
53. Agency for Healthcare Research and Quality (AHRQ). Healthcare innovations exchange: bilingual, culturally competent community health workers increase insurance enrollment, access to care, and self-efficacy among low-income Latinos. 2012.